Free Trial

OraSure Technologies (OSUR) Competitors

OraSure Technologies logo
$3.22 -0.01 (-0.31%)
Closing price 04:00 PM Eastern
Extended Trading
$3.22 0.00 (0.00%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

OSUR vs. CERS, UTMD, ANIK, WST, COO, ALGN, MMSI, ICUI, XRAY, and HAE

Should you be buying OraSure Technologies stock or one of its competitors? The main competitors of OraSure Technologies include Cerus (CERS), Utah Medical Products (UTMD), Anika Therapeutics (ANIK), West Pharmaceutical Services (WST), Cooper Companies (COO), Align Technology (ALGN), Merit Medical Systems (MMSI), ICU Medical (ICUI), DENTSPLY SIRONA (XRAY), and Haemonetics (HAE). These companies are all part of the "health care supplies" industry.

OraSure Technologies vs. Its Competitors

Cerus (NASDAQ:CERS) and OraSure Technologies (NASDAQ:OSUR) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, institutional ownership, earnings, media sentiment, profitability and risk.

Cerus has a net margin of -9.81% compared to OraSure Technologies' net margin of -36.84%. OraSure Technologies' return on equity of -10.81% beat Cerus' return on equity.

Company Net Margins Return on Equity Return on Assets
Cerus-9.81% -33.77% -9.32%
OraSure Technologies -36.84%-10.81%-9.44%

In the previous week, Cerus and Cerus both had 5 articles in the media. Cerus' average media sentiment score of 1.52 beat OraSure Technologies' score of 0.22 indicating that Cerus is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cerus
2 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
OraSure Technologies
2 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

OraSure Technologies has lower revenue, but higher earnings than Cerus. Cerus is trading at a lower price-to-earnings ratio than OraSure Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cerus$180.27M1.34-$20.92M-$0.10-12.60
OraSure Technologies$138.53M1.70-$19.50M-$0.67-4.81

78.4% of Cerus shares are held by institutional investors. Comparatively, 93.5% of OraSure Technologies shares are held by institutional investors. 3.4% of Cerus shares are held by insiders. Comparatively, 3.9% of OraSure Technologies shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Cerus presently has a consensus target price of $3.50, indicating a potential upside of 177.78%. OraSure Technologies has a consensus target price of $3.00, indicating a potential downside of 6.83%. Given Cerus' stronger consensus rating and higher probable upside, equities research analysts clearly believe Cerus is more favorable than OraSure Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cerus
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
OraSure Technologies
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Cerus has a beta of 1.63, indicating that its stock price is 63% more volatile than the S&P 500. Comparatively, OraSure Technologies has a beta of 0.44, indicating that its stock price is 56% less volatile than the S&P 500.

Summary

Cerus beats OraSure Technologies on 9 of the 15 factors compared between the two stocks.

Get OraSure Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for OSUR and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OSUR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OSUR vs. The Competition

MetricOraSure TechnologiesMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$235.50M$10.54B$5.70B$10.27B
Dividend YieldN/A1.86%5.72%4.60%
P/E Ratio-4.8121.3875.8626.51
Price / Sales1.7028.37491.12165.50
Price / Cash85.2625.0025.8129.89
Price / Book0.593.4312.846.32
Net Income-$19.50M$212.47M$3.28B$270.51M
7 Day Performance-3.88%-0.99%0.22%2.15%
1 Month Performance16.67%2.17%4.61%6.35%
1 Year Performance-26.82%-10.93%68.33%25.49%

OraSure Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OSUR
OraSure Technologies
1.8945 of 5 stars
$3.22
-0.3%
$3.00
-6.8%
-27.4%$235.50M$138.53M-4.81840
CERS
Cerus
3.0912 of 5 stars
$1.30
-2.3%
$3.50
+169.2%
-42.0%$254.96M$180.27M-13.00290News Coverage
Positive News
Short Interest ↓
UTMD
Utah Medical Products
3.2202 of 5 stars
$63.35
-0.1%
N/A-8.1%$203.24M$40.90M16.94180Positive News
ANIK
Anika Therapeutics
4.4335 of 5 stars
$8.94
flat
$18.00
+101.3%
-64.9%$128.90M$114.55M-2.15300
WST
West Pharmaceutical Services
4.9874 of 5 stars
$253.30
+1.0%
$320.71
+26.6%
-14.3%$18.03B$2.89B37.9210,600News Coverage
Positive News
Analyst Forecast
COO
Cooper Companies
4.4572 of 5 stars
$68.79
+1.0%
$86.64
+25.9%
-40.8%$13.54B$3.90B33.8916,000Positive News
ALGN
Align Technology
4.925 of 5 stars
$136.86
-1.6%
$215.00
+57.1%
-46.2%$10.08B$4.00B23.0820,945Positive News
MMSI
Merit Medical Systems
4.7607 of 5 stars
$92.33
-0.7%
$107.00
+15.9%
-13.8%$5.51B$1.36B46.877,400Positive News
ICUI
ICU Medical
4.6123 of 5 stars
$130.58
-0.5%
$179.00
+37.1%
-26.2%$3.24B$2.37B-85.9115,000Positive News
XRAY
DENTSPLY SIRONA
4.9369 of 5 stars
$14.21
-2.8%
$18.64
+31.1%
-48.5%$2.92B$3.67B-3.0014,000Positive News
HAE
Haemonetics
4.8808 of 5 stars
$54.02
-0.7%
$85.18
+57.7%
-32.5%$2.62B$1.35B16.523,023

Related Companies and Tools


This page (NASDAQ:OSUR) was last updated on 9/16/2025 by MarketBeat.com Staff
From Our Partners